4.8 Article

Alzheimer's vulnerable brain region relies on a distinct retromer core dedicated to endosomal recycling

期刊

CELL REPORTS
卷 37, 期 13, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2021.110182

关键词

-

资金

  1. NIH [AG034618, AG035015, P30AG066462, NS056049, AG051556]
  2. Alz-heimer's Disease Neuroimaging Initiative (ADNI) (NIH) [U01 AG024904]
  3. Department of Defense ADNI [W81XWH-12-2-0012]
  4. National Institute on Aging
  5. National Institute of Biomedical Imaging and Bioengineering
  6. AbbVie
  7. Alzheimer's Association
  8. Alzheimer's Drug Discovery Foundation
  9. Araclon Biotech
  10. BioClinica, Inc.
  11. Biogen
  12. Bristol-Myers Squibb Company
  13. CereSpir, Inc.
  14. Cogstate
  15. Eisai Inc.
  16. Elan Pharmaceuticals, Inc.
  17. Eli Lilly and Company
  18. EuroImmun
  19. F. Hoffmann-La Roche, Ltd.
  20. Genentech, Inc.
  21. Fujirebio
  22. GE Healthcare
  23. IXICO, Ltd.
  24. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  25. Johnson & Johnson Pharmaceutical Research & Development, LLC.
  26. Lumosity
  27. Lund-beck
  28. Merck Co., Inc.
  29. Meso Scale Diagnostics, LLC.
  30. NeuroRx Research
  31. Neurotrack Technologies
  32. Novartis Pharmaceuticals Corporation
  33. Pfizer, Inc.
  34. Piramal Imaging
  35. Servier
  36. Takeda Pharmaceutical Company
  37. Transi-tion Therapeutics
  38. Canadian Institutes of Health Research

向作者/读者索取更多资源

The study reveals a potential general mechanism that can explain the regional vulnerability of Alzheimer's disease, linking pathogenic disruptions in endosomal trafficking to its anatomical vulnerability, particularly in the trans-entorhinal cortex. VPS26b is found to mediate regionally selective synaptic dysfunction and SORL1 deficiency, providing insights into the pathogenesis of AD.
Whether and how the pathogenic disruptions in endosomal trafficking observed in Alzheimer's disease (AD) are linked to its anatomical vulnerability remain unknown. Here, we began addressing these questions by showing that neurons are enriched with a second retromer core, organized around VPS26b, differentially dedicated to endosomal recycling. Next, by imaging mouse models, we show that the trans-entorhinal cortex, a region most vulnerable to AD, is most susceptible to VPS26b depletion-a finding validated by electrophysiology, immunocytochemistry, and behavior. VPS26b was then found enriched in the trans-entorhinal cortex of human brains, where both VPS26b and the retromer-related receptor SORL1 were found deficient in AD. Finally, by regulating glutamate receptor and SORL1 recycling, we show that VPS26b can mediate regionally selective synaptic dysfunction and SORL1 deficiency. Together with the trans-entorhinal's unique network properties, hypothesized to impose a heavy demand on endosomal recycling, these results suggest a general mechanism that can explain AD's regional vulnerability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据